Near-infrared spectrophotometry can be used to measure cerebral concentrations of oxyhemoglobin and deoxyhemoglobin. This has been applied to developing methods for quantifying cerebral blood volume glob i which is relevant for the investigation of the pathogenesis of brain injury in newborn infants as well as older infants. This study investigates the internal consistency between measurements of CBV using two methods: the oxygen method, which is able to determine absolute values of CBV, and the total Hb method, which can detect changes in CBV only. Cerebral blood flow (CBF) was also measured. Fifteen premature infants were examined. Due to practical problems, in only eight of these was a minimum of two CBF and two CBV values obtained both before and after a change in arterial Pco, of at least 0.5 kPa. A significant difference between the CBV-CO, reactivity found by the two methods was demonstrated: 0.89 mUlOO g/kPa (95% confidence interval = 0.63-1.26) for the oxygen method and 0.22 mUlOO g/kPa (95% confidence interval = 0.084.36) for the total Hb method. This finding is substantiated by the absolute values of CBV [mean value = 3.7 mUlOO g (SD = 1.1)], CBF [mean value = 11.3 mUlOO glmin (SD = 5.9)], and CBF reactivity 159 2 9% (SEM)]. All the values Measuring CBV is relevant in the investigation of the pathophysiology of hemorrhagic and hypoxic-ischemic brain injury. Methods used so far for absolute quantification such as radioactive erythrocyte labeling have not been feasible for clinical practice.
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NIRS is a method for measuring changes in [Hb] and [HbO,] using the Beer-Lambert relationship between the attenuation of the emitted light and the concentration of absorber. This has led to methods for quantifying CBF and CBV (1, 2) . NIRS is a relatively fast, easily reproducible, noninvasive method that may appeal to clinicians for use in a number of settings. In particular it is tempting to use the directly available trace of the sum of correspond well with previous findings, although the CBV reactivity determined by the oxygen method has not been reported previously. The reason for the discrepancy between the two methods is unclear, but induced changes in the scattering properties of the brain would give rise to errors influencing the total Hb method rather than the oxygen method. (Pediatr Res 36: 20-24, 1994) Abbreviations CBV, cerebral blood volume CBV,, cerebral blood volume measured by the oxygen method CBV,, change in cerebral blood volume as detected by the total Hb method CBF, cerebral blood flow CBF,, cerebral blood flow measured by the oxygen method NIRS, near-infrared spectrophotometry Sat, arterial oxygen saturation [Hb] , cerebral concentration of deoxyhemoglobin [HbO,], cerebral concentration of oxyhemoglobin FiO,, fraction of inspired oxygen 01, oxygenation index CI, confidence interval the oxyhemoglobin and deoxyhemoglobin signals, the total Hb, as an indicator for changes in CBV, and it has already been used in a number of reports (3) (4) (5) (6) (7) .
The aim of this study was to quantitate the CBV-CO, reactivity in stable preterm infants and to investigate the agreement between two different methods of CBV measurements using NIRS that have not previously been applied simultaneously to test their validity before application in a clinical setting. Also, the agreement with the CBF-CO, reactivity was investigated, because C B F as measured by NIRS has already been validated against other (invasive) techniques.
2 1 fiberoptic cables. This means that the light has to travel through two kinds of substance: variable and invariable. Invariable substances are those that either do not absorb in the near-infrared region or do so but at a constant level. Among these are the skull, the hair, the skin and its pigment, and the optical coupling itself.
The variable substances in the near-infrared region in question are oxyhemoglobin and deoxyhemoglobin (and cytochrome aa,, although it absorbs significantly less) (8) . The average [HbO,] and [Hb] are determined by a modification of the Beer-Lambert law: OD = e-celeb + k, where OD is the measured attenuation of the emitted light in optical densities; e is the extinction coefficient of the chromophore in m~-' -c m -' ; c is the concentration of the chromophore in mM; 1 is the distance between the points where light enters and leaves the tissue in cm; b is a differential path length factor that accounts for the light not traveling directly from the sending fiber to the receiving fiber because of multiple scattering in the tissue; and k is the attenuation caused by invariable absorbers and invariable scatter.
Procedures. The fibers were placed bifrontally with a distance of 4-5 cm, resulting in an interfiber angle of approximately 90°, i.e. in a reflection-like geometry. Due to lack of direct determination of optical path length, we used the interoptode distance in cm multiplied by a fixed path length factor of 4.4 (9) . [HbO,] and [Hb] were calculated from the attenuation of the emitted light at three wavelengths, i-e. 774, 806, and 910 nm (3). The 845-nm wavelength was deliberately omitted from the algorithm because it has the maximum sensitivity for attenuation due to cytochrome aa,, a signal not relevant in this context. A sampling rate of 21s was used for CBF, measurements and 118 s for CBV, and ACBV, measurements.
The total Hb method. Changes in blood volume, e.g. with changing Pco,, may be measured directly by NIRS, inasmuch as the sum of oxyhemoglobin and deoxyhemoglobin, the total Hb, changes proportionally with the change in CBV, i.e. ACBV, = k.A([HbO,]+[Hb]) (the total Hb method) (3). Here, k = 4-100/(Hb.R-1.05), where Hb is the peripherally measured blood Hb content in mmol/L (monoheme), R is the cerebral-to-large-vessel hematocrit ratio (0.69), and 1.05 is the brain density. The factor 4 indicates that the absorption coefficients used to convert the measured attenuation (in optical densities) into Hb concentration are based on tetraheme standards. The change in total Hb concentration was calculated as the difference between the mean value of at least 20 samples before and after the Pco, change.
Oxygen method. The method to quantify CBV in absolute terms is based on the indicator dilution principle (2) . When the infant is clinically stable, oxyhemoglobin can be used as a tracer, because the CBF and the cerebral metabolic rate of oxygen consumption can be assumed to be constant. By increasing the amount of oxygen in the inspired air, inducing a small increase in Sat, the subsequent increase in [HbO,] and the corresponding decrease in [Hb] can be used to determine the total amount of cerebral Hb that is available for saturation. The total cerebral Hb is again directly proportional to the CBV. To measure CBV,, FiO, was increased by 0.1-0.2 for 2-5 min, a period sufficient to reach a new baseline. CBV, measurements with a short-term instability of the Sat signal exceeding 4% from the baseline were discarded.
Absolute CBV can therefore be calculated as ks(AHb0, -AHb/2*ASat), where k (path length, R, density, and Hb) is the same as before. The reason for using the 0 1 (AHbO, -AHb/2) is that this minimizes the bias due to changes in total Hb and increases the signal-to-noise ratio (10) . To avoid underestimating the CBV, due to the error on the ASat signal, the calculation of OIJASat was done as a regression of 0 1 over ASat over the whole time period, as well as the reciprocal value of the inverse regression. The square root of the product of these two values was used.
CBF measurements. To measure CBF, FiO, was increased to 1.00 for 10-20 s. Mean values of 0 1 and Sat were determined, and CBF was calculated as described by Skov et al. (1 1).
Patients and study design. Three CBV, and three CBF, measurements were attempted before and after an arterial PCO, change of at least 0.5 kPa in 15 newborn infants without birth asphyxia or intracranial hemorrhage (as detected by ultrasound) who therefore could be expected to have intact cerebral CO, reactivity. All the infants were stable and mechanically ventilated, with arterial blood pressure and blood gases within the normal ranges in 24%48% oxygen supply. A change in Pco, was induced by altering the ventilator rate slightly. The measuring periods for CBV, and CBF, measurements were spaced 10-20 min, thereby allowing the arterial Pco, to stabilize. Pco, was measured transcutaneously, and values were sampled at the same rate as above. Transcutaneous values were in each infant validated against at least one blood sample (arterial or capillary heel sample). The instrument is susceptible to movement artifacts, and the amount of time that the infant needs to lie still to complete the series of measurements often exceeds 45 min. Furthermore, the Pco, had to remain at a constant level both before and after the change. To be able to induce an arterial saturation increase, the FiO, of the infants before the study had to be higher than 0.21. Infants with intraventricular hemorrhage were not excluded from the study. Because it is imperative for the accuracy of the results that the optodes remain in the same position throughout the measurements and because all of the aforementioned criteria had to be complied with, practical problems prevented adequate measurements from being carried out in all infants.
In eight of the infants (gestational ages 25-32 wk, birth weights 890-2630 g), at least two CBF, and two CBV, at at least two CO, levels were successfully measured both before and after the change in arterial Pco,, i.e. 66 CBV, and 60 CBF, were determined at 31 different Pco, values.
Statistics. The design of this study was to perform repeated measures of CBF and CBV. Intrasituation variabilities were tested using analysis of variance. CO, reactivities were determined using analysis of covariance. Linear regressions of mean values of CBF versus CBV, before the CO, change in each child and of ACBF versus ACBV, values were performed (calculated as the change until next stable Pco, value). Due to expected upward skewness of the CBF, values as well as the CBV, values, the significance levels were checked by calculating the regressions on logarithmically transformed values. No important differences in significance were found. Finally, the two methods for calculating CBV were compared using the Wilcoxon signed rank sum test.
Ethics. Written informed parental consent was obtained in all cases and the project was approved by the regional ethical committee for Copenhagen and found in accordance with the Helsinki 11 declaration.
RESULTS
Mean CBF was 11.3 mLllOO g/min (SD = 5.9). The intrasituation variability, i.e. the test-retest variation, was 39% (analysis of variance). Mean CBV, was 3.7 mL1lOO g (SD = 1.1), with a test-retest variation of 23%. Fig. 2, upperpanel) .
The intraindividual CBF-CO, reactivity was 59 + 9% (SEM) (analysis of covariance). The intraindividual CBV,-CO, reactivity was 23 2 8% (SEM) (Table l), corresponding to 0.89 mL1100 g/kPa (95% CI = 0.63-1.26). In comparison, the CBV,-CO, reactivity was 0.22 mLllOO g/kPa (95% CI = 0.08-0.36). The mean difference between the results of the two methods was 0.67 mLllOO g/kPa (95% CI = 0.31-1.03).
The relation between the CBV responses determined by the two methods was statistically significant @ < 0.05 using the Wilcoxon signed rank sum test; Fig. 2, lower  panel) .
DISCUSSION
The CBV-CO, reactivity estimated by the total Hb method was approximately 4 times less than that of the oxygen method. This suggests that some of the assumptions used for NIRS quantitation of H b concentrations are insufficient.
The CBV, reactivity corresponds well with those reactivities reported previously (4-6). The CBV index reactivity reported by Pryds et al. (3) can be compared with these results by assuming an average interoptode distance of 5 cm. The resulting, much lower, CBV,-CO, reactivity of 0.08 mLllOO g/kPa matches the much lower CBF reactivity of 17%/kPa reported in that study.
The CBV, reactivity has not previously been determined. To substantiate the results, absolute CBV,, CBF, and CBF reactivity were also measured. CBV, corresponded with that reported by Wyatt et al. (2) using the same method, considering the difference in regression technique. To our knowledge, the only other study of absolute CBV in newborn infants (12) used a different method-"CO-labeled erythrocytes-and resulted in markedly higher values. This may be a result of all five infants in that study being small for date, severely hypoglycemic, or asphyxiated. The values in human adults are about 5 mLllOO g (13) . The values of CBF, CBF,, ob- Figure 2 . Upperpanel, The C02-induced change in CBF in each infant plotted against the concurrent change in CBV,. The relation was highly significant. Lowerpanel, The C0,-induced change in CBV as detected by the oxygen method and by the total Hb method. --* GA, gestational age; PNA, postnatal age; BW, birth weight; CBV,1 is CBV before CO, change measured by the oxygen method in mUl00 g; CBV,2 is CBV after CO, change measured by the oxygen method in mLIl00 g; ACBV, is the change in CBV measured by the total Hb method in mL1100 g; CBF, is CBF before CO, change in mLI100 g/min; CBF, is CBF after CO, change in mLIl00 g/min; and ACO, is the change in CO,.
tained in this study correspond well with previous reports that of CBF (15) , which can be explained by a relatively (11) . The CBF reactivities, however, are relatively high, lesser increase in vascular diameter than in flow. the normal value being around 30%/kPa (14) . It is well The difference in CBV-CO, reactivities determined by established that the reactivity of CBV to CO, is less than the two methods therefore seems real. Although the 24 BRUN AND GREISEN number of patients in our study was limited, the difference between the two methods was highly significant, the ---95% CI being 0.31-1.03 mLIlOO g/kPa. The reason for the difference is unclear. CBVo depends on oxygen being an inert tracer in the concentrations used. Although this may be questionable (lo), a systematic overestimation of CBVo-CO, reactivity seems unlikely. The CBVt-CO, reactivity depends on a stable NIRS signal throughout the study period; the drift of the device, however, is negligible. When a major change in absorption occurs as a result of Pco,-induced change in total cerebral Hb concentration, a change in optical path length is expected. In principle, this invalidates the total Hb method. The oxygen method would not be influenced to the same degree. Calculation using the diffusion approximation (16) , however, shows that the error is small. Change in optical path length could result from changes in the scattering properties of the brain and other tissues between the optical fibers. The influx of red blood cells in itself introduces more scatterers. Increased CBV is associated with increased brain volume and shifts of the cerebrospinal fluid. Capillary recruitment may change the localization of absorption of light within the brain. All these phenomena are hypothetical, however, and we can only guess about the magnitudes of their respective influences. In the future, it may be possible to measure mean optical path length continuously (17) and to investigate directly dynamic changes in tissue characteristics.
In conclusion, the oxygen method and the total Hb method yield significantly different values of CBV and CBV-CO, reactivity. In a clinical setting, it is therefore impossible to perform quantitatively accurate measurements of CO, reactivity, a parameter of potential interest in determining whether hypoxic-ischemic brain injury has occurred. The reason for the difference is unclear and requires further investigation, e.g. by direct measurement of optical path length. The oxygen method appears to be associated with the least amount of potential error.
